ArrowMark Colorado Holdings’s Organogenesis Holdings ORGO Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,615	Closed	-$28.6K	–	321
2022 Q4	$28.6K	Hold	10,615	–	–	﹤0.01%	301
2022 Q3	$34K	Hold	10,615	–	–	﹤0.01%	323
2022 Q2	$52K	Hold	10,615	–	–	﹤0.01%	319
2022 Q1	$81K	Hold	10,615	–	–	﹤0.01%	339
2021 Q4	$98K	Hold	10,615	–	–	﹤0.01%	329
2021 Q3	$151K	Hold	10,615	–	–	﹤0.01%	351
2021 Q2	$176K	Sell	10,615 -1,217	-10%	-$22.7K	﹤0.01%	339
2021 Q1	$216K	Hold	11,832	–	–	﹤0.01%	338
2020 Q4	$89K	Hold	11,832	–	–	﹤0.01%	331
2020 Q3	$45K	Sell	11,832 -16,008	-58%	-$63.2K	﹤0.01%	333
2020 Q2	$107K	Hold	27,840	–	–	﹤0.01%	297
2020 Q1	$90K	Hold	27,840	–	–	﹤0.01%	302
2019 Q4	$134K	Hold	27,840	–	–	﹤0.01%	309
2019 Q3	$183K	Buy	+27,840	New	+$155K	﹤0.01%	314
2018 Q4	–	Sell	-2,382,176	Closed	-$24.1M	–	356
2018 Q3	$24.1M	Sell	2,382,176 -24,000	-1%	-$242K	0.2%	107
2018 Q2	$24.1M	Buy	2,406,176 +613	+0%	+$6.14K	0.22%	106
2018 Q1	$23.8M	Buy	2,405,563 +15,037	+0.6%	+$150K	0.24%	111
2017 Q4	$23.7M	Buy	+2,390,526	New	+$23.7M	0.24%	107

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ArrowMark Colorado Holdings's ORGO Position: Q1 2023 in Review

ArrowMark Colorado Holdings sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 10,615 shares — an estimated $28.6K sold.

ArrowMark Colorado Holdings first reported a position in ORGO in Q4 2017 and held it in 18 quarters. The position peaked at $24.1M in Q3 2018. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

ArrowMark Colorado Holdings reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
ArrowMark Colorado Holdings sold 10,615 Organogenesis Holdings shares in Q1 2023, an estimated $28.6K.
ArrowMark Colorado Holdings first reported a position in Organogenesis Holdings in Q4 2017 and held it in 18 quarters.
ArrowMark Colorado Holdings's Organogenesis Holdings position peaked at $24.1M in Q3 2018.
131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2023, filed 15 May 2023.